AI-powered third-party admin Marpai has announced it will add a value-based care provider NuvoAir, a leading virtual specialty care provider focused on managing patients with complex heart and lung conditions, to its Marpai Connect platform.
NuvoAir offers same-day virtual care appointments for people with cardiopulmonary conditions, such as chronic obstructive pulmonary disease, chronic heart failure, and asthma. Individuals can connect with respiratory therapists, care coordinators, nurses, health coaches, cardiologists and pulmonologists.
Marpai offers AI-powered health plan administration for self-funded employers and, through its Marpai Connect platform, matches its members with value-based healthcare providers.
NuvoAir will be added to the Marpai Connect platform for members of the administrator’s self-funded employer health plan and their families.
“We are excited to offer NuvoAir to treat the costly heart and lung conditions faced by members of the health plans we manage,” Marpai CEO Edmundo Gonzalez said in a statement. “With NuvoAir, members and their families can easily access care that can dramatically improve their health and quality of life and avoid costly emergency room visits and hospitalizations, allowing employers and their respective health plans to ‘save a lot of money.’
THE GREAT TREND
In 2021, Boston-based NuvoAir, which also has an office in Sweden, raised $12 million (€10 million) in Series A funding to expand its chronic disease management and clinical trial platforms.
Last year, the company announced a $11 million extension to his Series A round, bringing his total raise to $25 million.
The listed company Marpai has announced its Q2 2023 revenue forecast between $9.5 million and $9.8 million. It also announced that its EBITDA and net profit should increase in the second quarter of the year, compared to the first quarter.
Another company in the field of heart health management is Hello Heart, creator of an app-based platform designed to help employees manage hypertension, heart rate and cardiovascular health. Last year, the company secured $70 million to expand its hypertension management service.